Toward a new therapy for tuberculosis.
Rubin
Eric J
EJ
School of Public Health, Harvard University, Boston, USA.
D000818:Animals; D000904:Antibiotics, Antitubercular / Q000494:pharmacology / Q000627:therapeutic use*; D064687:Diarylquinolines; D024881:Drug Resistance, Bacterial / Q000235:genetics; D006801:Humans; D051379:Mice; D009154:Mutation; D020102:Mycobacterium smegmatis / Q000187:drug effects / Q000235:genetics; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D064687:Diarylquinolines; D011804:Quinolines; C493870:bedaquiline